Alexander J Ambinder

9PUBLICATIONS
23CO-AUTHORS
Haematological tumoursHaematologyRegenerative medicine (incl. stem cells)Medical mycologyTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Jan 22, 2026
Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI.

Marti Goldenberg, Ravi Varadhan, Christopher J Gamper

|Dec 03, 2025
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.

Daniel T Peters, Deedra Nicolet, Yazan F Madanat

|May 07, 2024
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.

Ilias Sinanidis, Michael J Hochman, Hua-Ling Tsai

|Jan 05, 2024
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide.

Niveditha Ravindra, Laura W Dillon, Gege Gui

|Jul 31, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.

Michael J Hochman, Megan Othus, Robert P Hasserjian

Pageof 2

Frequent Collaborators

3 joint publications

Amy E DeZern

2 joint publications

Theodoros Karantanos

2 joint publications

Tania Jain

1 joint publications

Megan Othus